Protagen Collaborates with Bayer Schering on Endometriosis Biomarker Discovery
June 11, 2010
Protagen Collaborates with Bayer Schering on Endometriosis Biomarker Discovery
The company will explore the use of its UNIarray protein chip technology for the discovery of autoantibody patterns that are predictive of the disease.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Protagen to ID Protein Biomarkers in Support of Biogen's MS Drug Development Work
April 1, 2011 / ProteoMonitor - Protagen Secures Nearly $13M in Funding for Diagnostics Work and Protein Biomarker Validation
September 10, 2010 / ProteoMonitor - Protagen Using UNIarray Platform to ID Biomarkers for Use in Lupus Drug Development
August 5, 2011 / ProteoMonitor - SuppreMol to Use Protagen Biomarker Panel
August 2, 2011 / GenomeWeb Daily News - Protagen Receives Japanese Patent for UNIclone Technology
August 13, 2010 / ProteoMonitor